DOCSLIB.ORG

Boldly Going Where No Group Has Gone Before: Medical Genomics in the Wilds of Deepest Darkest North Queensland Alan G Baxter James Cook University, Townsville, Qld

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Boldly Going Where No Group Has Gone Before: Medical Genomics in the Wilds of Deepest Darkest North Queensland Alan G Baxter James Cook University, Townsville, Qld NEWSLETTER PP 100000910 ISSN 1442-8725 June 2014 Boldly Going Where No Group Has Gone Before: Medical Genomics in the Wilds of Deepest Darkest North Queensland Alan G Baxter James Cook University, Townsville, Qld. In 2003, my research group relocated from the Centenary would continue in my new the Centenary Institute, on the Royal Prince home. I had attributed these successes to my Alfred Hospital campus and adjacent to the own abilities to judge people, and, knowing University of Sydney, to the Townsville that JCU had a world class marine biology Campus of James Cook University (JCU). research endeavour, assumed that we would At that time, the University had not held have little trouble in recruiting skilled and NHMRC funding for over a decade. The enthusiastic staff. In retrospect, this was a last (and only previous) recipient had moved mistake. JCU had a strong “Tech College” there on a training fellowship and moved mentality (it was formed by a merger between away again within a year. The campus a teaching college and a school of the consisted of brutalist concrete bunkers University of Queensland) and undeniably adorned with concrete sheets protecting the tropics attracts, as Noel Coward used to windows from cyclone damage, and wide note, some odd sorts. I failed to follow the expanses of the area’s original fl ora – a dry, wisest advice I have ever received, that of Jon sparse woody scrub and native grassland Sedgwick when he said, “Only ever employ populated by wandering mobs of wallabies, nice people.” I learned my lesson, and after soaring cacophanies of cockatoos, and a many attempts to change the lab culture, vibrant collection of tropical butterfl ies. our original expeditionary force rebooted and repopulated the lab – this time carefully Our lab was carved out of the ground fl oor observing the Sedgwick rule. of the largely derelict, but still occupied, Alan Baxter Molecular Sciences Building. Various JCU has some of the best administrative staff physical restrictions crimped the amount of I have met anywhere: bright, enthusiastic offi ce space, but the lab design was practical and constructive. Of course, like anywhere, and safe, and far better than the rows of it also has some who are not so helpful, but Contents glass boxes architects seem to prefer. A unlike some larger institutions, none of these new animal facility was built specifi cally to are malevolent. In addition, we received Boldly Going ... 1 house the kind of work we do, which is the very strong support from the Faculty. I had Editorial 3 study of gene/environment interactions in been recruited to establish a viable medical President’s Column 11 autoimmunity. This required very fi ne levels research endeavour and to a considerable Honorary Secretary’s News 12 of environmental control and the resulting extent, I was given a free rein. The Research facility – the fi rst building on the campus to Offi ce was refocused and prioritised to act Upcoming Conferences 12 have an exterior colour scheme – remains as facilitators, rather than gate-keepers, of Visiting Speaker Program 13 one of the best small animal facilities in funding. Finance reporting was changed to Three to One! 16 Australia. provide year-by-year accounts, instead of whole-of-grant double entry book-keeping. DoI 2014, Victoria 20 In moving, most of our, and certainly all of A gradual acceptance grew that competitive Councillors’ News 25 my, attention was focussed on practical and research was hard and that teaching loads Travel Award Conference Reports 29 physical requirements. To a large extent, I had to be seriously lightened for productive had assumed that the decade-long run of researchers. Publications List 33 gifted staff and students I had enjoyed at cont.p4 ASI Inc. Newsletter June 2014 ASI Inc. COUNCIL Non-Voting Councillors: Newsletter Editor President Vice President Dr Simon Apte Professor Dale Godfrey Professor Christopher Goodnow Ph: 61 7 3362 0380 Dept Microbiology & Immunology Department of Immunology Email: [email protected] Peter Doherty Institute JCSMR, ANU University of Melbourne Parkville Vic 3010 PO Box 334, Canberra ACT 2601 Journal Editor Ph: 61 3 8344 6831 Ph: 61 2 6125 2394 Dr Gabrielle Belz Email: [email protected] Email: [email protected] Ph: 61 3 9345 2544 Fax: 61 3 9347 0852 Email: [email protected] Honorary Secretary Honorary Treasurer A/Prof. Stuart Berzins Dr John Stambas Visiting Speakers Co-ordinator CRN Section, School of Health Sciences AAHL, CSIRO Deakin Collaborative Lab. A/Prof. J. Alejandro Lopez Federation University Australia Private Bag 24 Ph: 61 7 3845 3794 Fax: 61 7 3845 3510 Mt Helen Vic 3352 East Geelong Vic 3220 Email: a.lopez@griffi th.edu.au Ph: 61 3 5320 2039 Ph: 61 3 5227 5740 Email: [email protected] Email: [email protected] Day of Immunology Co-ordinator Dr Claerwen Jones State Councillors Ph: 61 3 8344 9595 Fax: 61 3 9347 1540 New South Wales Victoria & Tasmania Email: [email protected] Dr Marcel Batten Dr Daniel Gray Ph: 61 2 9295 8412 Ph: 61 3 9345 2497 Meeting Co-ordinator Email: [email protected] Email: [email protected] Dr Susanne Heinzel Ph: 61 3 9345 2609 Fax: 61 3 9347 0852 Queensland South Australia & Northern Territory Email: [email protected] Dr Kristen Radford Dr Cara Fraser Ph: 61 7 3443 7638 Ph: 0422 903 093 Council Member of IUIS Email: [email protected] Email: [email protected] Professor Alan Baxter Ph: 61 7 4781 6265 Western Australia Australian Capital Territory Email: [email protected] Dr Andrew Currie Dr Anselm Enders Ph: 61 8 9360 7426 Ph: 61 2 6125 7605 FIMSA Councillor Email: [email protected] Email: [email protected] Professor Alan Baxter Ph: 61 7 4781 6265 New Zealand Email: [email protected] Dr Roslyn Kemp Ph: 64 3 479 7708 Honorary Archivist: Email: [email protected] Dr Judith Greer Project Manager Ph: 61 7 3346 6018 Miss Sarah Fardy Email: [email protected] Ph: 61 3 5227 5794 / 0413 917 990 ICI2016 Councillor Email: [email protected] Professor Jose Villadangos Administrative Correspondence Ph: 61 3 9035 7684 Ms Judi Anderson Email: [email protected] ASI Inc. Secretariat PO Box 7108 Upper Ferntree Gully Vic 3156 Ph: 61 3 9756 0128 Fax: 61 3 9753 6372 Email: [email protected] The New ASI Website The ASI web site (www.immunology.org.au) has been fully remodelled and updated. New services include: Links providing members with free access to Immunology & Cell Biology, Nature Immunology, Nature Reviews Immunology Special offers for ASI members Download and upload forms for ASI awards Positions vacant page Online membership renewal Upcoming conference listings Women's initiative Twitter feed as well as many links to sites of immunological interest at home and abroad. If you would like to advertise a job or conference, or if you have an immunology news story, or a favourite immunology-related site that you would like to see linked to the ASI website, please email Sarah Fardy at [email protected] 2 ASI Inc. Newsletter June 2014 EDITORIAL Confusing Times for Medical and children under 16 will have to pay for the Thanks to Alan Baxter for his entertaining Researchers fi rst 10 visits per year – now I know some article, it’s a great perspective on a very people go to their GP more than once every interesting career. It really is fantastic It was only three years ago we were fi ghting 5.2 weeks, but many of those people will be that contributors like Alan and his team against proposed cuts to the NHMRC concessional patients and won’t contribute fi nd the time to put an article together for budget that would have more-than halved more than $50 p/a to the fund. Now my maths the Newsletter. I like his ideas about only the available funding. Now, without even a ain’t so good, but, best-case scenario: if every employing nice people, unfortunately that’d fi ght, it seems we are in for the sort of support woman, man and child goes to the GP 10 probably rule me out of a job in his lab – I we wouldn’t have dared dream of with the times/year – that gives us $50 x 22,680,000 guess I wouldn’t make it past the ice bucket Government’s proposed Medical Research = $1.3bn p/a into the fund, x 8 years (+ a anyway! Future Fund. This proposed fund is predicted kickstart of $1bn of uncommitted funds from to reach $20bn by 2023 and will act as an the existing Health and Hospitals Fund) gives Thanks also to other contributors in this endowment – where revenue from the fund us a fund of $10.7bn. Revenue from the fund edition, including Claerwen Jones and will act as a revenue stream to the NHMRC. will apparently add to the NHMRC revenue Susan Christo. Their reports on the Day That’s great news for medical research but stream from 2015-16 (so not compounding); of Immunology in Victoria and the Tri- does come at a loss to other areas of scientifi c that means that more than $9bn will have to University Dinner in Adelaide are great research. As my kids would say – too bad, so be made up by other health reforms. This examples of ASI reaching out and sharing sad; but hang on, before you exercise your leaves me in a confused state and more than the marvel of immunology.
Load more

Recommended publications
  • Tumor Therapy in Mice Via Antigen Targeting to a Novel, DC- Restricted C-Type Lectin
    Tumor therapy in mice via antigen targeting to a novel, DC- restricted C-type lectin David Sancho, … , James R. Carlyle, Caetano Reis e Sousa J Clin Invest. 2008;118(6):2098-2110. https://doi.org/10.1172/JCI34584. Research Article Immunology The mouse CD8α+ DC subset excels at cross-presentation of antigen, which can elicit robust CTL responses. A receptor allowing specific antigen targeting to this subset and its equivalent in humans would therefore be useful for the induction of antitumor CTLs. Here, we have characterized a C-type lectin of the NK cell receptor group that we named DC, NK lectin group receptor-1 (DNGR-1). DNGR-1 was found to be expressed in mice at high levels by CD8+ DCs and at low levels by plasmacytoid DCs but not by other hematopoietic cells. Human DNGR-1 was also restricted in expression to a small subset of blood DCs that bear similarities to mouse CD8α+ DCs. The selective expression pattern and observed endocytic activity of DNGR-1 suggested that it could be used for antigen targeting to DCs. Consistent with this notion, antigen epitopes covalently coupled to an antibody specific for mouse DNGR-1 were selectively cross-presented by CD8α+ DCs in vivo and, when given with adjuvants, induced potent CTL responses. When the antigens corresponded to tumor-expressed peptides, treatment with the antibody conjugate and adjuvant could prevent development or mediate eradication of B16 melanoma lung pseudometastases. We conclude that DNGR-1 is a novel, highly specific marker of mouse and human DC subsets that can be exploited for CTL cross-priming and tumor therapy.
    [Show full text]
  • BIOLOGY 639 SCIENCE ONLINE the Unexpected Brains Behind Blood Vessel Growth 641 THIS WEEK in SCIENCE 668 U.K
    4 February 2005 Vol. 307 No. 5710 Pages 629–796 $10 07%.'+%#%+& 2416'+0(70%6+10 37#06+6#6+8' 51(69#4' #/2.+(+%#6+10 %'..$+1.1); %.10+0) /+%41#44#;5 #0#.;5+5 #0#.;5+5 2%4 51.76+105 Finish first with a superior species. 50% faster real-time results with FullVelocity™ QPCR Kits! Our FullVelocity™ master mixes use a novel enzyme species to deliver Superior Performance vs. Taq -Based Reagents FullVelocity™ Taq -Based real-time results faster than conventional reagents. With a simple change Reagent Kits Reagent Kits Enzyme species High-speed Thermus to the thermal profile on your existing real-time PCR system, the archaeal Fast time to results FullVelocity technology provides you high-speed amplification without Enzyme thermostability dUTP incorporation requiring any special equipment or re-optimization. SYBR® Green tolerance Price per reaction $$$ • Fast, economical • Efficient, specific and • Probe and SYBR® results sensitive Green chemistries Need More Information? Give Us A Call: Ask Us About These Great Products: Stratagene USA and Canada Stratagene Europe FullVelocity™ QPCR Master Mix* 600561 Order: (800) 424-5444 x3 Order: 00800-7000-7000 FullVelocity™ QRT-PCR Master Mix* 600562 Technical Services: (800) 894-1304 Technical Services: 00800-7400-7400 FullVelocity™ SYBR® Green QPCR Master Mix 600581 FullVelocity™ SYBR® Green QRT-PCR Master Mix 600582 Stratagene Japan K.K. *U.S. Patent Nos. 6,528,254, 6,548,250, and patents pending. Order: 03-5159-2060 Purchase of these products is accompanied by a license to use them in the Polymerase Chain Reaction (PCR) Technical Services: 03-5159-2070 process in conjunction with a thermal cycler whose use in the automated performance of the PCR process is YYYUVTCVCIGPGEQO covered by the up-front license fee, either by payment to Applied Biosystems or as purchased, i.e., an authorized thermal cycler.
    [Show full text]
  • Green Biotechnology: Kill Or Cure?
    issue 11 winter 2008|2009 promoting excellence in the molecular life sciences in europe Dear Reader, Green biotechnology: kill or cure? Recognising excellence is core to EMBO – the member- ship has been doing just that since nomination of the fi rst 200 EMBO Members in the 1960’s. This year again we welcome newly elected members to EMBO (see page 4). And we congratulate Luc Montagnier, Roger Tsien and Harald zur Hausen – EMBO Members awarded The Nobel Prize this year. The discipli- nary breadth of molecular life sciences is much broader today than it was some 40 years ago. For this reason, a modifi ed member election procedure was adopted – see page 5. You may have noticed some changes to format in this issue of EMBOencounters: fi rst, you are hearing from me as Deputy Director – a role I share with EMBO Fellowships Programme Manager Jan Taplick. Secondly, we plan a lead story for each issue to highlight © www.goldenrice.org topics relevant to EMBO activities. Golden Rice could help prevent vitamin A defi ciency in the developing world. This issue’s lead story investigates today’s Soaring grain prices, high energy costs and increasingly louder riots on the streets of perceptions of the green revolution – the focus famine-stricken countries such as Haiti or Somalia are forcing politicians and the public of the next EMBO/EMBL Science & Society to reconsider their opposition to modern agriculture and crops created through breed- Conference. EMBO Science & Society aims to ing techniques that employ methods of molecular genetics. Will the fi erce opposition of create dialogue between policy makers and western countries to so-called genetically modifi ed (GM) crops eventually give way to the public and complements our numerous the acceptance that they might help tackle the global food crisis and even prevent some activities that share knowledge addressing the diseases? challenges of our changing world.
    [Show full text]
  • Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens
    Article Myosin II Synergizes with F-Actin to Promote DNGR- 1-Dependent Cross-Presentation of Dead Cell- Associated Antigens Graphical Abstract Authors Oliver Schulz, Pavel Hanc, Jan P. Bo¨ ttcher, Robbert Hoogeboom, Sandra S. Diebold, Pavel Tolar, Caetano Reis e Sousa Correspondence [email protected] In Brief Schulz et al. show that dead cells lacking myosin II have a diminished capacity to serve as antigen donors for dendritic cells that express the DNGR-1 receptor. DNGR-1 binds to F-actin exposed on cell corpses, and myosin II organizes actin filaments into bundles that cross-link the receptor more efficiently. Highlights d Myosin II amplifies the activity of the DNGR-1 ligand F-actin d Lack of myosin II in donor cells reduces DNGR-1-dependent cross-presentation d Beads with F-actin and myosin II can target antigens to cDC1 for CD8 T cell priming Schulz et al., 2018, Cell Reports 24, 419–428 July 10, 2018 ª 2018 The Francis Crick Institute. https://doi.org/10.1016/j.celrep.2018.06.038 Cell Reports Article Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens Oliver Schulz,1 Pavel Hanc, 1,5 Jan P. Bo¨ ttcher,1 Robbert Hoogeboom,2,6 Sandra S. Diebold,3 Pavel Tolar,2,4 and Caetano Reis e Sousa1,7,* 1Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK 2Immune Receptor Activation Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK 3Biotherapeutics Division, National Institute for Biological Standards and Control, Potters
    [Show full text]
  • Actin Is an Evolutionarily-Conserved Damage-Associated Molecular
    RESEARCH ARTICLE Actin is an evolutionarily-conserved damage-associated molecular pattern that signals tissue injury in Drosophila melanogaster Naren Srinivasan1†, Oliver Gordon1†, Susan Ahrens1‡, Anna Franz2, Safia Deddouche1§, Probir Chakravarty3, David Phillips4, Ali A Yunus5, Michael K Rosen5, Rita S Valente6, Luis Teixeira6, Barry Thompson7, Marc S Dionne8, Will Wood9, Caetano Reis e Sousa1* 1Immunobiology Laboratory, The Francis Crick Institute, London, United Kingdom; 2Department of Biochemistry, Biomedical Sciences, University Walk, University of Bristol, Bristol, United Kingdom; 3Bioinformatics, The Francis Crick Institute, London, United Kingdom; 4Genomics-Equipment Park, The Francis Crick Institute, London, United Kingdom; 5Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, United States; 6Instituto Gulbenkian de Cieˆncia, Oeiras, Portugal; 7Epithelial Biology Laboratory, The Francis Crick Institute, *For correspondence: caetano@ London, United Kingdom; 8Department of Life Sciences and MRC Centre for crick.ac.uk Molecular Bacteriology and Infection, South Kensington Campus, Imperial College 9 †These authors contributed London, London, United Kingdom; Department of Cellular and Molecular Medicine, equally to this work Biomedical Sciences, University of Bristol, Bristol, United Kingdom Present address: ‡Voisin Consulting Life Sciences, Surrey, United Kingdom; §Open Innovation Access Platform, Abstract Damage-associated molecular patterns (DAMPs) are molecules released by dead cells Sanofi Strasbourg, Strasbourg, that trigger sterile inflammation and, in vertebrates, adaptive immunity. Actin is a DAMP detected France in mammals by the receptor, DNGR-1, expressed by dendritic cells (DCs). DNGR-1 is phosphorylated by Src-family kinases and recruits the tyrosine kinase Syk to promote DC cross- Competing interests: The presentation of dead cell-associated antigens. Here we report that actin is also a DAMP in authors declare that no invertebrates that lack DCs and adaptive immunity.
    [Show full text]
  • Centro Nacional De Investigaciones Cardiovasculares, Carlos III (CNIC) Melchor Fernández Almagro, 3, 28029, Madrid, Tel
    DAVID SANCHO , Ph.D. Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC) Melchor Fernández Almagro, 3, 28029, Madrid, Tel. (+34) 914531200 ext 2010, [email protected] http://www.cnic.es/en/inflamacion/inmunobiologia/index.php CURRENT POSITIONS Oct 2020 President of Biomedicine Area, State Agency for Research, Ministry of Science and Innovation. Oct 2016 Associate Professor and Group Leader, Immunobiology lab, Myocardial Pathophysiology Area, CNIC. EDUCATION Nov 2003 Ph.D. degree in Sciences Thesis: “Role of CD69 in immune and inflammatory response” Grade: Sobresaliente “cum laude” by unanimity, highest honours Advisor: Dr. Francisco Sánchez-Madrid. Department of Molecular Biology, Madrid Autonomous University. Awards: - Extraordinary Prize to doctoral thesis by Madrid Autonomous University - Prize to best doctoral thesis (2003-2004) by the Centre of Molecular Biology “Severo Ochoa”, Madrid Autonomous University. - “Ramón Areces” prize from the National Royal Academy of Doctors to the best doctoral thesis. May 2000 Clinical Specialization in Immunology. Spanish Health and Education Ministries. Immunology Service, La Princesa Hospital, Madrid. July 1995 BSc degree School of Biology. Murcia University (GPA 4/4). Awards: - Extraordinary Prize by Murcia University. - First National Prize in Biology to the best academic performance at the National level during the complete degree, Spanish Education Ministry (1995). PREVIOUS POSITIONS Aug 2017-Sep2020 Coordinator Immunity, Infection and New Therapies, subarea of the Biomedicine Area, State Agency for Research, Ministry of Science and Innovation. Sept 2010-Sep2016 Assistant Professor and Group Leader, Immunobiology lab, Myocardial Pathophysiology Area, CNIC. 1 Sep 2015-Jun2017 Honorary Professor at Biochemistry Department of Universidad Autónoma de Madrid. Sept 2009- Aug 2010 Junior I Group Leader at the CNIC, Spanish National Centre for Cardiovascular Research.
    [Show full text]
  • Gene THERAPY
    PROJECT SYNOPSES Interested in European research? Research*eu is our quarterly magazine keeping you in touch with main developments (results, pro- grammes, events, etc.). It is available in English, French and German. A free sample copy or free subscription can be obtained from: European Commission Directorate-General for Research Information and Communication Unit B-1049 Brussels Fax (32-2) 29-58220 E-mail: [email protected] Internet: http://europa.eu.int/comm/research/rtdinfo/index_en.html EUROPEAN COMMISSION Directorate F – Health Unit F5 – Health Biotechnology Contact: Charles Kessler Office CDMA 2/188 Tel (32-2) 29 56112 Fax (32-2) 29 94693 E-mail: [email protected] EUROPEAN COMMISSION NEW THERAPIES EU-supported research in Genomics and Biotechnology for Health Sixth Framework Programme (2002-2006) Edited by Charles Kessler Directorate-General for Research 2007 Life Sciences, Genomics and Biotechnology for Health EUR 22841 NEW THERAPIES TABLE OF CONTENTS INTRODUCTION 11 REGeneratiVE MEDICINE 15 EuroStemCell THERAPEUSKIN European consortium for stem cell research 17 Ex vivo gene therapy for recessive dystrophic epi- dermlysis bullosa : preclinical and clinical studies GENOSTEM 44 Adult mesenchymal stem cells engineering for connective tissue disorders. From the bench to BetaCellTherapy the bed side 22 Beta cell programming for treatment of diabetes 47 OsteoCord Bone from blood: optimised isolation, characteri- EuroSTEC sation and osteogenic induction of mesenchy- Soft tissue engineering for congenital birth mal stem cells from umbilical cord blood 27 defects in children: new treatment modalities for spina bifida, urogenital and abdominal wall TherCord defects 52 Development and preclinical testing of cord blood-derived cell therapy products 30 SC&CR Application and process optimisation of human EPISTEM stem cells for myocardium reapair 57 Role of p63 and related pathways in epithelial stem cell proliferation and differentiation and in STEMSTROKE rare EEC-related syndromes.
    [Show full text]
  • Acknowledgment of Reviewers, 2009
    Proceedings of the National Academy ofPNAS Sciences of the United States of America www.pnas.org Acknowledgment of Reviewers, 2009 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2009. Their generous contribution is deeply appreciated. A R. Alison Adcock Schahram Akbarian Paul Allen Lauren Ancel Meyers Duur Aanen Lia Addadi Brian Akerley Phillip Allen Robin Anders Lucien Aarden John Adelman Joshua Akey Fred Allendorf Jens Andersen Ruben Abagayan Zach Adelman Anna Akhmanova Robert Aller Olaf Andersen Alejandro Aballay Sarah Ades Eduard Akhunov Thorsten Allers Richard Andersen Cory Abate-Shen Stuart B. Adler Huda Akil Stefano Allesina Robert Andersen Abul Abbas Ralph Adolphs Shizuo Akira Richard Alley Adam Anderson Jonathan Abbatt Markus Aebi Gustav Akk Mark Alliegro Daniel Anderson Patrick Abbot Ueli Aebi Mikael Akke David Allison David Anderson Geoffrey Abbott Peter Aerts Armen Akopian Jeremy Allison Deborah Anderson L. Abbott Markus Affolter David Alais John Allman Gary Anderson Larry Abbott Pavel Afonine Eric Alani Laura Almasy James Anderson Akio Abe Jeffrey Agar Balbino Alarcon Osborne Almeida John Anderson Stephen Abedon Bharat Aggarwal McEwan Alastair Grac¸a Almeida-Porada Kathryn Anderson Steffen Abel John Aggleton Mikko Alava Genevieve Almouzni Mark Anderson Eugene Agichtein Christopher Albanese Emad Alnemri Richard Anderson Ted Abel Xabier Agirrezabala Birgit Alber Costica Aloman Robert P. Anderson Asa Abeliovich Ariel Agmon Tom Alber Jose´ Alonso Timothy Anderson Birgit Abler Noe¨l Agne`s Mark Albers Carlos Alonso-Alvarez Inger Andersson Robert Abraham Vladimir Agranovich Matthew Albert Suzanne Alonzo Tommy Andersson Wickliffe Abraham Anurag Agrawal Kurt Albertine Carlos Alos-Ferrer Masami Ando Charles Abrams Arun Agrawal Susan Alberts Seth Alper Tadashi Andoh Peter Abrams Rajendra Agrawal Adriana Albini Margaret Altemus Jose Andrade, Jr.
    [Show full text]
  • BSI Congress 2019: Looking to Liverpool
    IJunemmunology 2019 | ISSN 1356-5559 (print) News BSI Congress 2019: Looking to Liverpool T cell response BSI Forum: Set your alarm: in IBD: Representing you Adjusting to life A new pathway in industy www.immunology.org 2 ADVERTISEMENTS REPORTER CELL LINES Reporter Cells: PRRs (TLRs, RLRs...) Highlighted signaling pathways CDS (STING, cGAS...) Inflammasome test cells InvivoGen offers a large panel of cell lines that are stably transfected Transcription factor with innate immunity-specific pathway reporter constructs. Cytokine Our cells are compatible for High Throughput Screening. Autophagy Also available: Detection reagents Innovation within reach Selective antibiotics www.invivogen.com/reporter-cells Antimicrobial agents Immunology News | June 2019 A WORD FROM THE EDITOR 3 ©Shutterstock/Prokopenko Oleg ©Shutterstock/Prokopenko Welcome to the summer edition of members working in all sectors of Immunology News. Activities at the BSI immunology. On pages 22–23, one of continue to move on apace and we have our Editorial Board members, Mihil been busy planning new activities to both Patel, discusses his recent move from support our members and represent academia to industry, examining the immunology on a wider stage. challenges and benefits of moving between Preparation for our 2019 Congress is different sectors and giving his top tips now truly underway and we look forward to to those considering such a move. welcoming many of you to Liverpool on 2–5 As well as supporting members in different December. One of the Congress highlights sectors, we aim to work with subject areas is always our Bright Sparks session which aligned to immunology to drive research takes place on the first afternoon of the event forward – you can read about our new and showcases the work of our brilliant early partnership with the National Cancer career researchers.
    [Show full text]
  • A-Actinin Accounts for the Bioactivity of Actin Preparations in Inducing STAT
    RESEARCH ADVANCE a-actinin accounts for the bioactivity of actin preparations in inducing STAT target genes in Drosophila melanogaster Oliver Gordon1†, Conor M Henry1†, Naren Srinivasan1‡, Susan Ahrens1§, Anna Franz2, Safia Deddouche1#, Probir Chakravarty3, David Phillips4¶, Roger George5, Svend Kjaer5, David Frith6, Ambrosius P Snijders6, Rita S Valente7, Carolina J Simoes da Silva8, Luis Teixeira7, Barry Thompson9, Marc S Dionne10, Will Wood11, Caetano Reis e Sousa1* 1Immunobiology Laboratory, The Francis Crick Institute, London, United Kingdom; 2Department of Biochemistry, Biomedical Sciences, University of Bristol, Bristol, United Kingdom; 3Bioinformatics, The Francis Crick Institute, London, United Kingdom; 4Genomics-Equipment Park, The Francis Crick Institute, London, United Kingdom; 5Structural Biology, The Francis Crick Institute, London, United Kingdom; 6Proteomics, The Francis Crick Institute, London, United Kingdom; 7Instituto *For correspondence: Gulbenkian de Ciencia, Oeiras, Portugal; 8Department of Life Sciences, Imperial [email protected] College London, London, United Kingdom; 9Epithelial Biology Laboratory, The †These authors contributed Francis Crick Institute, London, United Kingdom; 10MRC Centre for Molecular equally to this work Bacteriology and Infection, Imperial College London, London, United Kingdom; Present address: 11Edinburgh Medical School, MRC Centre for Inflammation Research, University of ‡GlaxoSmithKline, Stevenage, Edinburgh, Edinburgh, United Kingdom United Kingdom; §Voisin Consulting Life Sciences,
    [Show full text]
  • ERK Signaling Controls Innate-Like CD8+ T Cell Differentiation Via the ELK4 (SAP-1) and ELK1 Transcription Factors
    ERK Signaling Controls Innate-like CD8+ T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors This information is current as Diane Maurice, Patrick Costello, Mathew Sargent and of September 28, 2021. Richard Treisman J Immunol 2018; 201:1681-1691; Prepublished online 1 August 2018; doi: 10.4049/jimmunol.1800704 http://www.jimmunol.org/content/201/6/1681 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2018/07/31/jimmunol.180070 Material 4.DCSupplemental http://www.jimmunol.org/ References This article cites 39 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/201/6/1681.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 28, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice Freely available online through The Journal of Immunology Author Choice option Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 The Authors All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology ERK Signaling Controls Innate-like CD8+ T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors Diane Maurice, Patrick Costello, Mathew Sargent, and Richard Treisman In mouse thymocyte development, signaling by the TCR through the ERK pathway is required for positive selection of conventional naive T cells.
    [Show full text]
  • Acknowledgment of Reviewers, 2017
    Acknowledgment of Reviewers, 2017 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2017. Their generous contribution is deeply appreciated. A Katarzyna P. Adamala Hiroji Aiba Christine Alewine Jean Alric Hillie Aaldering Andrew Adamatzky Erez Lieberman Aiden Caroline M. Alexander Eben Alsberg Lauri A. Aaltonen Jozef Adamcik Allison E. Aiello R. Todd Alexander Manfred Alsheimer Duur K. Aanen Igor Adameyko Iannis Aifantis Alfredo Alexander-Katz Grégoire Altan-Bonnet Matthew L. Aardema Vic Adamowicz Christopher Aiken Anastassia N. Lee Altenberg Dirk G. A. L. Aarts David J. Adams Roger D. Aines Alexandrova Galit Alter Adam R. Abate David J. Adams Tracy D. Ainsworth Frank Alexis Orly Alter Cory Abate-Shen Jonathan Adams Edoardo Airoldi Emil Alexov Florian Altermatt Peter Abbamonte Michael E. Adams Jacqueline Michael Alfaro Marcus Altfeld Abul K. Abbas Patti Adank Aitkenhead-Peterson Hashim M. Al-Hashimi Dario C. Altieri Emmanuel A. Abbe R. Alison Adcock Slimane Ait-Si-Ali Asfar Ali Katye E. Altieri Shahal Abbo Zach N. Adelman Joanna Aizenberg Nageeb Ali Amnon Altman David H. Abbott Robert S. Adelstein Javier Aizpurua Robin R. Ali John D. Altman Geoffrey W. Abbott Andrew Adey Jaffer A. Ajani Saleem H. Ali Steven Altschuler Nicholas L. Abbott W. Neil Adger Caroline M. Ajo-Franklin Karen Alim Andrea Alu Omar Abdel-Wahab Jess F. Adkins Myles Akabas Michael T. Alkire Veronica A. Alvarez Ibrokhim Y. Ralph Adolphs Michael Akam Suvarna Alladi Javier Álvarez Abdurakhmonov Markus Aebi Omar S. Akbari Frédéric H.-T. Allain Arturo Alvarez-Buylla Ikuro Abe Yehuda Afek Erol Akcay David Alland David Amabilino Junichi Abe Hagit P.
    [Show full text]